...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Participation of protease-activated receptor-1 in thrombin-induced microglial activation.
【24h】

Participation of protease-activated receptor-1 in thrombin-induced microglial activation.

机译:蛋白酶激活受体1参与凝血酶诱导的小胶质细胞激活。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Activation of microglia, the resident macrophages in the CNS, plays a significant role in neuronal death or degeneration in a broad spectrum of CNS disorders. Recent studies indicate that nanomolar concentrations of the serine protease, thrombin, can activate microglia in culture. However, in contrast to other neural cells responsive to thrombin, the participation of novel protease-activated receptors (PARs), such as the prototypic thrombin receptor PAR1, in thrombin-induced microglial activation was cast in doubt. In this report, by utilizing primary microglial cultures from PAR1 knockout (PAR1-/-) mice, application of the PAR1 active peptide TRAP-6 (SFLLRN) in comparison to a scrambled peptide (LFLNR), we have unambiguously demonstrated that murine microglia constitutively express PAR1 mRNA that is translated into fully functional protein. Activation of the microglial PAR1 induces a rapid cytosolic free [Ca2+]i increase and transient activation of both p38 and p44/42 mitogen-activated protein kinases. Moreover, although in part, this PAR1 activation directly contributes to thrombin-induced microglial proliferation. Furthermore, although not directly inducing tumor necrosis factor-alpha (TNF-alpha) release, PAR1 activation up-regulates microglial CD40 expression and potentiates CD40 ligand-induced TNF-alpha production, thus indirectly contributing to microglial activation. Taken together, these results demonstrate an essential role of PAR1 in thrombin-induced microglial activation. In addition, strategies aimed at blocking thrombin signaling through PAR1 may be therapeutically valuable for diseases associated with cerebral vascular damage and significant inflammation with microglial activation.
机译:小胶质细胞(中枢神经系统中的常驻巨噬细胞)的激活在广泛的中枢神经系统疾病中,在神经元死亡或变性中起着重要作用。最近的研究表明,纳摩尔浓度的丝氨酸​​蛋白酶,凝血酶可以激活培养物中的小胶质细胞。但是,与其他对凝血酶有反应的神经细胞相反,新型蛋白酶激活受体(PAR)(例如原型凝血酶受体PAR1)在凝血酶诱导的小胶质细胞激活中的参与受到怀疑。在此报告中,通过利用来自PAR1基因敲除(PAR1-/-)小鼠的原代小胶质细胞培养物,将PAR1活性肽TRAP-6(SFLLRN)与加扰肽(LFLNR)进行比较,我们明确地证明了小鼠小胶质细胞组成性表达被翻译成全功能蛋白的PAR1 mRNA。小胶质细胞PAR1的激活诱导了胞浆中游离[Ca2 +] i的快速增加,以及p38和p44 / 42丝裂原激活的蛋白激酶的瞬时激活。而且,尽管部分地,该PAR1激活直接促成凝血酶诱导的小胶质细胞增殖。此外,虽然不直接诱导肿瘤坏死因子-α(TNF-α)释放,但PAR1激活上调了小胶质CD40的表达并增强了CD40配体诱导的TNF-α的产生,从而间接促进了小胶质细胞的活化。综上所述,这些结果证明了PAR1在凝血酶诱导的小胶质细胞活化中的重要作用。此外,针对通过PAR1阻断凝血酶信号传导的策略对于与脑血管损伤和小胶质细胞活化引起的严重炎症相关的疾病可能具有治疗价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号